The data obtained in the present study demonstrate, for the first time, that cervical cancer cells present DPPIV/CD26 enzymatic activity, whether linked to cell membrane or in its soluble form, revealing a differential expression that in turn translate to a modification in cell migration. The gene discussed is FAP; the disease is cervical cancer.